Kwality Pharmaceuticals Ltd

NSE: KPL · BSE: 539997 · Pharmaceuticals & Biotechnology · 21 announcements

Kwality Pharmaceuticals Ltd news stories on ALFA NewsRead the news →

Share price: ₹3,728.15
Market cap: ₹3,868 Cr
Revenue (annual): ₹503.1 Cr
Net profit (annual): ₹67.35 Cr
P/E (TTM): 47.7×Sector 47.4×
Promoter holding: 54.86%-0.01% QoQ
FII holding: 3.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Earnings Call 4 Financial Results 3 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Regulatory Approval 1 Debt & Borrowing 1 Credit Rating 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 15:38 IST BSE

Debt & Borrowing

Kwality Pharmaceuticals Debt & Borrowing: ₹28.47 Cr

Kwality Pharmaceuticals Ltd confirmed it does not meet the SEBI criteria for identification as a Large Corporate as of March 31, 2026. The company reported outstanding borrowings of ₹28.47 Crore and maintains a BBB credit rating from ICRA Limited. This disclosure is a routine regulatory compliance filing regarding debt-raising frameworks.

Value: ₹28.47 Cr

Read the filing ↗